AURKB / Aurora kinase B · Western blot design guide

Design a Western Blot for AURKB

Real validated AURKB Western blot protocols, expected-band and isoform facts, troubleshooting for weak or shifted signal, and recommended anti-AURKB WB antibodies. Everything you need to plan the experiment before you commit precious samples.

Evidence assembled September 2026 · For research use; verify linked source records and product datasheet before use
Western blot protocol sheet for AURKB: expected band ~39.3 kDa, hero antibody A00762, catalog values and labelled standard workflow; separate PMC comparisons on the guide
Printable AURKB Western blot protocol sheet — expected band ~39.3 kDa, antibody A00762, controls and PMC citations. Open the full AURKB WB guide →

AURKB Western Blot Experimental Design Guide

Expected bands, validated protocols, controls and antibodies — the at-a-glance facts below, then the full design guide.

Must know before running
Expected band ~39.3 kDa
Gel 12–15% (standard starting point)
Positive control ⓘ Appendix (IHC candidate; verify WB) +4 more
Negative control ⓘ Adipose tissue (IHC candidate; verify WB)
Important caveats
Reasons your observed band may differ from the expected size.
PTM Phosphorylated + Acetylated
Caveat Phosphorylation-state controls
Gene-set association MSigDB Hallmark membership
Isoform 5 isoform(s)
Section 1

Real Curated AURKB Western Blot Protocols

The A00762 protocol combines labelled catalog values with standard starting conditions. Published comparisons retain their own sample, reagent and detection scope.

Recommended Western blot protocol parameters
Sample / lysateH1792 (40ug), HCT116 (40ug), LOVO (40ug) (catalog A00762)
Gel %12–15% (standard starting point)
Load20–30 µg total protein per lane; optimize for abundance (standard starting point)
TransferStandard semi-dry transfer; verify efficiency (standard starting point)
Membrane0.45 µm PVDF (standard starting point)
Blocking5% milk or 5% BSA in TBST (standard starting point)
Primary antibodyA00762; use the WB datasheet starting dilution (standard starting point)
Primary incubationOvernight at 4 °C (standard starting point)
Secondary antibodySpecies-matched HRP conjugate at validated dilution (standard starting point)
Secondary incubation1 h at room temperature (standard starting point)
Wash3 × 5 min in TBST (standard starting point)
DetectionECL; bracket exposures to avoid saturation (standard starting point)
Section 2

What Is the Expected AURKB Western Blot Band Size?

AURKB is predicted at 39.3 kDa; isoforms could affect migration, but no empirical band or distinct isoform pattern is supplied.

What am I looking at on my blot?
Band near 39.3 kDaConsistent with the predicted AURKB mass; confirm identity with controls
Several bands at different positionsCould reflect AURKB splice isoforms, though distinct migration is unproven
Band below 39.3 kDaCould be an AURKB isoform; its mass is not supplied
Band above 39.3 kDaCould be an AURKB isoform; its mass is not supplied
💡Expected AURKB appearanceUniProt predicts AURKB at 39.3 kDa, but no empirical band size or isoform migration pattern is supplied; verify any candidate band with identity controls.
How each factor affects band size
UniProt predicted massPlaces the reference band near 39.3 kDa
Splice isoform 1Its individual mass and migration relative to other isoforms are unknown
Splice isoforms 2 and 3Their individual masses and migration relative to other isoforms are unknown
Splice isoforms 4 and 5Their individual masses and migration relative to other isoforms are unknown
Why is my band missing or off?
SituationLikely causeNext action
No band in lysateNuclear and chromosome-associated AURKB may be poorly recoveredCheck extraction of the nuclear fraction and use a positive-control lysate
Band higher than expectedIsoform identity or nonspecific binding is unresolvedCompare with an AURKB depletion control
Band lower than expectedAn isoform or degradation could account for the bandCheck sample integrity and compare with an AURKB depletion control
Multiple bandsFive annotated isoforms exist, but their migration is unknownIdentify AURKB-dependent bands with a depletion control
Weak or no signalAURKB may be poorly recovered from nuclear materialVerify nuclear extraction and test a positive-control lysate

Sample controls for AURKB Western blot

🧪HPA-IHC candidate guidance (verify in WB): For positive controls for AURKB in Western blot, you can use appendix tissue lysate, which HPA scores High.
Positive control: Appendix (IHC candidate; verify WB)
Negative control: Adipose tissue (IHC candidate; verify WB)
Loading controls: Run GAPDH, β-actin, and a total-protein stain such as Ponceau alongside the samples.
⚠️Feasibility: AURKB is intracellular, and HPA scores adipose tissue Not detected, though a negative lysate may still need validation.

HPA tissue expression evidence for AURKB

Comprehensive Human Protein Atlas IHC scoring per tissue. Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.

Higher expression tissues · candidate positive controls from IHC

TissueCell typeLevelEvidenceSource
Appendix endocrine cells High Protein (IHC) HPA →
Colon endocrine cells High Protein (IHC) HPA →
Duodenum endocrine cells High Protein (IHC) HPA →
Rectum endocrine cells High Protein (IHC) HPA →
Skin cells in basal layer High Protein (IHC) HPA →

Lower expression tissues · IHC evidence, not confirmed WB-negative controls

TissueCell typeLevelEvidenceSource
Adipose tissue adipocytes Not detected Protein (IHC) HPA →
Caudate glial cells Not detected Protein (IHC) HPA →
Cerebellum cells in granular layer Not detected Protein (IHC) HPA →
Cervix glandular cells Not detected Protein (IHC) HPA →
Epididymis glandular cells Not detected Protein (IHC) HPA →
Section 3

Advanced AURKB Western Blot Tips

Deeper troubleshooting and optimisation questions for AURKB, answered from its protein features.

Where should the main AURKB band appear?
Band shift · The canonical sequence predicts 39.3 kDa. No observed band position is supplied, so use 39.3 kDa as a starting reference, not a confirmed migration position. The listed modifications alone do not establish a visible shift.
Could AURKB isoforms produce additional bands?
Isoforms · Five isoforms are listed. Isoform 4 lacks canonical residues 1–41, isoform 2 replaces residues 86–134, and isoform 3 lacks residues 142–344. These sequence differences could affect band size or antibody recognition; the supplied features do not establish which isoforms are present in a sample.
Which phosphorylation sites should a phospho-AURKB assay consider?
PTM · UniProt lists phosphothreonine at 35, 64 and 232, and phosphoserine at 62 and 227. Thr232 is annotated as autophosphorylated. Match the antibody’s stated site to these UniProt coordinates, checking its numbering convention before interpreting a phospho-specific band.

Yes. UniProt lists N6-acetyllysine at position 215. If measuring this modification, use an assay that distinguishes acetylated AURKB from total AURKB; the feature alone does not establish its occupancy or a visible mass shift.

Measure the phospho-specific signal and total AURKB signal separately, then compare phospho signal with total AURKB for the same samples. UniProt lists five phosphorylation sites, but their presence does not show how much protein is phosphorylated in a given sample.
Does this guide establish induction of AURKB?
Induction · No general induction response is established by this guide. A pathway or gene-set association is not evidence of induction in a particular specimen. Verify the relevant treatment and control in a target-specific experiment.
How should transfer be checked for AURKB?
Transfer · Standard workflow guidance: verify transfer efficiency for the intended target size before interpreting a weak signal. Use total-protein assessment and optimize transfer for the membrane, gel and apparatus; the labelled catalog values take precedence.
How should blocking be optimized?
Blocking · Standard workflow guidance: follow the A00762 datasheet where specified. Otherwise compare 5% milk or 5% BSA in TBST; for a phospho-specific assay start with BSA. Optimize background and specific signal with matched controls.
How should AURKB be quantified?
Quantitation · Standard workflow guidance: quantify only a validated target band within the linear exposure range. Use consistent sample preparation and loading, retain biological replicates, and avoid interpreting saturation or loading differences as regulation.
How should unexpected AURKB bands be interpreted?
Interpretation · First compare them with the 39.3 kDa canonical prediction and the listed isoform sequence changes. A band difference could warrant checking which isoforms an antibody can recognize. Phosphorylation and Lys215 acetylation are annotated, but those features alone cannot identify an unexpected band or explain an apparent mass difference.
Boster reagents

AURKB Western Blot Antibodies

Catalog antibodies with Western blot application and product-specific WB images. Evaluate suitability with the reported sample, controls and experimental conditions.

Real WB data Western blot (WB) analysis of AURKB/C (K197) pAb at 1:500 dilution Lane1:H1792 whole cell lysate(40ug) Lane2:HCT116 whole cell lysate(40ug) Lane3:LOVO whole cell lysate(40ug) Lane4:AML-12 whole cell lysate(40ug) Lane5:PMVEC whole cell lysate(40ug)
Anti-AURKB/C (K197) Antibody
Cat # A00762
Real WB data Western blot analysis of lysates from COS7 cells treated with Nocodazole 1ug/ml 16h, using AurB (Phospho-Thr232) Antibody. The lane on the right is blocked with the phospho peptide.
Anti-Phospho-ARK-2 (T232) AURKB Antibody
Cat # A00762T232
Real WB data Western blot analysis of Aurora B using anti-Aurora B antibody (M00762-1). Electrophoresis was performed on a 5-20% SDS-PAGE gel at 70V (Stacking gel) / 90V (Resolving gel) for 2-3 hours. The sample well of each lane was loaded with 30 ug of sample under reducing conditions. Lane 1: human Hela whole cell lysates, Lane 2: human 293T whole cell lysates, Lane 3: human Jurkat whole cell lysates, Lane 4: human U251 whole cell lysates. After electrophoresis, proteins were transferred to a nitrocellulose membrane at 150 mA for 50-90 minutes. Blocked the membrane with 5% non-fat milk/TBS for 1.5 hour at RT. The membrane was incubated with rabbit anti-Aurora B antigen affinity purified monoclonal antibody (Catalog # M00762-1) at 1:1000 overnight at 4°C, then washed with TBS-0.1%Tween 3 times with 5 minutes each and probed with a goat anti-rabbit IgG-HRP secondary antibody at a dilution of 1:500 for 1.5 hour at RT. The signal is developed using an Enhanced Chemiluminescent detection (ECL) kit (Catalog # EK1002) with Tanon 5200 system. A specific band was detected for Aurora B at approximately 39 kDa. The expected band size for Aurora B is at 39 kDa.
Anti-Aurora B AURKB Rabbit Monoclonal Antibody
Cat # M00762-1
Real WB data Western blot (WB) analysis of AURKB/C (K197) pAb at 1:500 dilution Lane1:HEK293T whole cell lysate(20ug) Lane2:HepG2 whole cell lysate(20ug) Lane3:PC3 whole cell lysate(40ug) Lane4:A549 whole cell lysate(40ug) Lane5:PC12 whole cell lysate(40ug) Lane6:AML-12 whole cell lysate(40ug)
Anti-AURKB/C (K197) Antibody
Cat # A00762-1

All four listed antibodies have WB images. A00762 and A00762-1 show AURKB/C (K197) blots of named whole-cell lysates. M00762-1 shows an approximately 39 kDa band in human lysates. A00762T232 shows phospho-Thr232 detection in treated COS7 lysate with phosphopeptide blocking. Evidence is limited to the shown conditions.

Which to pick: For phospho-Thr232, choose A00762T232. For Aurora B in human lysates, M00762-1 has a documented 39 kDa band. A00762 and A00762-1 list human, mouse, and rat reactivity; compare their pictured lysates with your planned sample.

Source: BosterBio AURKB gene-info card — filtered to Western-blot-capable antibodies; each card shows that product's actual WB validation figure.